Your browser doesn't support javascript.
loading
Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation.
Johnstone, Jeanette M; Leung, Brenda M Y; Srikanth, Priya; Hatsu, Irene; Perez, Leanna; Gracious, Barbara; Tost, Gabriella; Aman, Michael G; Gadow, Kenneth D; Findling, Robert L; Bukstein, Oscar; Arnold, L Eugene.
Affiliation
  • Johnstone JM; Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon.
  • Leung BMY; Department of Child and Adolescent Psychiatry, Oregon Health & Science University, Portland, Oregon.
  • Srikanth P; Faculty of Health Sciences, University of Lethbridge, Lethbridge, Alberta, Canada.
  • Hatsu I; School of Public Health, Oregon Health & Science University-Portland State University (OHSU-PSU Program), Portland, Oregon.
  • Perez L; Department of Human Sciences, The Ohio State University, Columbus, Ohio.
  • Gracious B; Department of Human Sciences, The Ohio State University, Columbus, Ohio.
  • Tost G; Department of Psychiatry and Behavioral Health, The Ohio State University, Columbus, Ohio.
  • Aman MG; Orange Park Medical Center, Orange Park, Florida.
  • Gadow KD; Department of Child and Adolescent Psychiatry, Oregon Health & Science University, Portland, Oregon.
  • Findling RL; The Nisonger Center UCEDD and Department of Psychology, The Ohio State University, Columbus, Ohio.
  • Bukstein O; Department of Psychiatry, Stony Brook University, Stony Brook, New York.
  • Arnold LE; Department of Psychiatry, Johns Hopkins University, Baltimore, Maryland.
J Child Adolesc Psychopharmacol ; 30(3): 166-172, 2020 04.
Article in En | MEDLINE | ID: mdl-32101469
ABSTRACT

Objective:

Study goals were to (1) provide a rationale for developing a composite primary outcome score that includes symptom severity for attention-deficit/hyperactivity disorder (ADHD) and emotional dysregulation, plus symptom-induced impairment; (2) demonstrate weighting methods to calculate the composite score using a sample of children diagnosed with ADHD and aggression; and (3) identify the optimal weighting method most sensitive to change, as measured by effect sizes.

Methods:

We conducted secondary data analyses from the previously conducted Treatment of Severe Childhood Aggression (TOSCA) study. Children aged 6-12 years were recruited through academic medical centers or community referrals. The composite primary outcome comprised the ADHD, oppositional defiant disorder, disruptive mood dysregulation disorder, and peer conflict subscales from the Child and Adolescent Symptom Inventory (CASI), a DSM (Diagnostic and Statistical Manual)-referenced rating scale of symptom severity and symptom-induced impairment. Five weighting methods were tested based on input from senior statisticians.

Results:

The composite score demonstrated a larger (Cohen's d) effect size than the individual CASI subscales, irrespective of the weighting method (10%-55% larger). Across all weighting methods, effect sizes were similar and substantial approximately a two-standard deviation symptom reduction (range -1.97 to -2.04), highest for equal item and equal subscale weighting, was demonstrated, from baseline to week 9, among all TOSCA participants. The composite score showed a medium positive correlation with the Clinical Global Impressions-Severity scores, 0.46-0.47 for all weighting methods.

Conclusions:

A composite score that included severity and impairment ratings of ADHD and emotional dysregulation demonstrated a more robust pre-post change than individual subscales. This composite may be a more useful indicator of clinically relevant improvement in heterogeneous samples with ADHD than single subscales, avoiding some of the statistical limitations associated with multiple comparisons. Among the five similar weighting methods, the two best appear to be the equal item and equal subscale weighting methods.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Attention Deficit and Disruptive Behavior Disorders / Affective Symptoms / Aggression Type of study: Guideline / Prognostic_studies Limits: Child / Female / Humans / Male Language: En Journal: J Child Adolesc Psychopharmacol Journal subject: PEDIATRIA / PSICOFARMACOLOGIA Year: 2020 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Attention Deficit and Disruptive Behavior Disorders / Affective Symptoms / Aggression Type of study: Guideline / Prognostic_studies Limits: Child / Female / Humans / Male Language: En Journal: J Child Adolesc Psychopharmacol Journal subject: PEDIATRIA / PSICOFARMACOLOGIA Year: 2020 Type: Article